应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
WXIBF Wuxi Biologics (Cayman) Inc
休市中 12-05 16:00:00 EST 延时
资讯
新帖
简况
美国OTC市场药明生物盘中异动 急速跳水7.56%报4.16美元
市场透视 · 11-19
美国OTC市场药明生物盘中异动 急速跳水7.56%报4.16美元
美国OTC市场药明生物盘中异动 大幅跳水6.15%
市场透视 · 10-22
美国OTC市场药明生物盘中异动 大幅跳水6.15%
创新药License-out火爆,价值重估进行时
同壁财经 · 10-22
创新药License-out火爆,价值重估进行时
CXO,一定要出去抢!
谈思生物 · 09-27
CXO,一定要出去抢!
药明生物8月8日成交额为770.00美元
市场透视 · 08-09
药明生物8月8日成交额为770.00美元
中华交易服务中国280指数上涨0.58%,前十大权重包含信达生物等
金融界 · 08-06
中华交易服务中国280指数上涨0.58%,前十大权重包含信达生物等
药明生物8月4日成交额为5339.00美元
市场透视 · 08-05
药明生物8月4日成交额为5339.00美元
百济神州要切入“CXO”,赛道未来是生态局?
盖德化工网 · 08-05
百济神州要切入“CXO”,赛道未来是生态局?
美国OTC市场药明生物盘中异动 早盘股价大跌6.06%报3.80美元
市场透视 · 08-04
美国OTC市场药明生物盘中异动 早盘股价大跌6.06%报3.80美元
中证香港内地股等权重指数报2226.67点,前十大权重包含快手-W等
金融界 · 08-04
中证香港内地股等权重指数报2226.67点,前十大权重包含快手-W等
中金医药8月组合:看好创新药及产业链 关注政策端积极变化
中金公司 · 08-04
中金医药8月组合:看好创新药及产业链 关注政策端积极变化
创新药“狂飙”与CXO“转型”,BD潮涌下的产业变局与新机
医药经济报 · 08-03
创新药“狂飙”与CXO“转型”,BD潮涌下的产业变局与新机
药明生物8月1日成交额为4045.00美元
市场透视 · 08-02
药明生物8月1日成交额为4045.00美元
中证沪港深500医药卫生指数下跌1.74%,前十大权重包含恒瑞医药等
金融界 · 08-01
中证沪港深500医药卫生指数下跌1.74%,前十大权重包含恒瑞医药等
图解丨南下资金净买入港股117亿港元,大幅加仓理想汽车
格隆汇 · 07-30
图解丨南下资金净买入港股117亿港元,大幅加仓理想汽车
药明生物再涨超3%宣布新加坡CRDMO中心模块化生物制剂生产厂启动建设
动脉网 · 07-30
药明生物再涨超3%宣布新加坡CRDMO中心模块化生物制剂生产厂启动建设
药明生物7月28日成交额为3236.00美元
市场透视 · 07-29
药明生物7月28日成交额为3236.00美元
【医药】集采“反内卷”,关注受益标的——医药生物行业周报
渤海证券研究 · 07-28
【医药】集采“反内卷”,关注受益标的——医药生物行业周报
药明生物涨4% 料中期净利同比增长约56%
金吾资讯 · 07-24
药明生物涨4% 料中期净利同比增长约56%
药明生物拟8月19日举行董事会会议批准中期业绩
格隆汇 · 07-24
药明生物拟8月19日举行董事会会议批准中期业绩
加载更多
公司概况
公司名称:
Wuxi Biologics (Cayman) Inc
所属市场:
PINK LIMITED
上市日期:
--
主营业务:
发行价格:
--
{"stockData":{"symbol":"WXIBF","market":"US","secType":"STK","nameCN":"Wuxi Biologics (Cayman) Inc","latestPrice":4.04,"timestamp":1764968400000,"preClose":4.04,"halted":0,"volume":0,"delay":15,"floatShares":3547495293,"shares":4070513076,"eps":0.107499,"marketStatus":"休市中","change":0,"latestTime":"12-05 16:00:00 EST 延时","open":4.04,"high":4.04,"low":4.04,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":0.107499,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1765184400000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"PINK LIMITED","adjPreClose":4.04,"volumeRatio":2.7988895798049285},"requestUrl":"/m/hq/s/WXIBF","defaultTab":"news","newsList":[{"id":"2584972045","title":"美国OTC市场药明生物盘中异动 急速跳水7.56%报4.16美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2584972045","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584972045?lang=zh_cn&edition=full","pubTime":"2025-11-19 23:29","pubTimestamp":1763566140,"startTime":"0","endTime":"0","summary":"北京时间2025年11月19日23时29分,美国OTC市场药明生物股票出现异动,股价大幅下挫7.56%。截至发稿,该股报4.16美元/股,成交量840股,换手率0.00%,振幅0.00%。美国OTC市场药明生物股票所在的生物技术行业中,整体跌幅为0.25%。美国OTC市场药明生物公司简介:无锡药明康德集团是一家生物药物的合同开发和制造组织,简称“CDMO”。无锡药明康德报告称,2020年收入为56亿元人民币,三年复合年增长率为51%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251119232901a704b14c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251119232901a704b14c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["WXIBF","BK4121"],"gpt_icon":0},{"id":"2577434908","title":"美国OTC市场药明生物盘中异动 大幅跳水6.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2577434908","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577434908?lang=zh_cn&edition=full","pubTime":"2025-10-22 22:52","pubTimestamp":1761144720,"startTime":"0","endTime":"0","summary":"北京时间2025年10月22日22时52分,美国OTC市场药明生物股票出现波动,股价急速下挫6.15%。美国OTC市场药明生物股票所在的生物技术行业中,整体跌幅为0.36%。美国OTC市场药明生物公司简介:无锡药明康德集团是一家生物药物的合同开发和制造组织,简称“CDMO”。它成立于 2010 年,隶属于药明康德,并于 2017 年在香港联交所上市。无锡药明康德报告称,2020年收入为56亿元人民币,三年复合年增长率为51%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251022225201a46ec888&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251022225201a46ec888&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["WXIBF","BK4121"],"gpt_icon":0},{"id":"2577633992","title":"创新药License-out火爆,价值重估进行时","url":"https://stock-news.laohu8.com/highlight/detail?id=2577633992","media":"同壁财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577633992?lang=zh_cn&edition=full","pubTime":"2025-10-22 11:15","pubTimestamp":1761102906,"startTime":"0","endTime":"0","summary":"医药魔方数据显示,2025年上半年License-out交易达72笔,已超2024年全年总量的一半;交易总金额较2024年全年高出16%,其中单笔超10亿美元的交易共16笔。License-out同期首付款总额首次超过一级市场融资总额,成为Biotech企业资金回流的关键路径,BD出海正逐步成为Biotech不可或缺的“输血”渠道。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251022111705a46d83ac&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251022111705a46d83ac&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06978","LU0320764599.SGD","BK1576","BK1583","BK1141","02269","LU0708995583.HKD","LU2125910500.SGD","LU2242644610.SGD","LU1046422090.SGD","LU2045819591.USD","BK1161","WXIBF","BK1574","LU0052750758.USD","02359"],"gpt_icon":0},{"id":"2570852976","title":"CXO,一定要出去抢!","url":"https://stock-news.laohu8.com/highlight/detail?id=2570852976","media":"谈思生物","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2570852976?lang=zh_cn&edition=full","pubTime":"2025-09-27 11:00","pubTimestamp":1758942050,"startTime":"0","endTime":"0","summary":"既然药圈高处不胜寒,干脆换个赛道,蹲一蹲 CXO 的“洼地”。把视野放大,扫了眼国内 CXO 出海战绩,又对照了 Lonza 这类全球龙头,心里大概有了粗线条图景。如图,净利润同比飙升54.8%,增速相当惹眼。倘若把全球CXO的终局比作一条终点线,药明生物的赛程才跑到一半——Ⅲ期收入占比尚未过半,天花板还远在天边。微观来看,这是重写CXO世界版图;宏观而言,更是在撬动现有国际规则——只有把旧秩序撕开裂缝,中国产业链才算真正跨出国门。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250927111944a6a165e1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250927111944a6a165e1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0979878070.USD","LU0052750758.USD","LU0456827905.SGD","LU0572944931.SGD","LU0516423091.SGD","SG9999002463.SGD","BK1521","LU0359201612.USD","LU2039709279.SGD","LU0456846285.SGD","LU0516422440.USD","LU0326950275.SGD","LU0516423174.USD","LU0417516738.SGD","LU0327786744.USD","LU0051755006.USD","LU0181495838.USD","LU1880383366.USD","LU0320764599.SGD","LU0708995583.HKD","LU0588546209.SGD","LU1688375341.USD","BK1141","LU0307460666.USD","LU0348735423.USD","LU0348825331.USD","BK1610","SG9999002562.SGD","BK1589","LU1242518931.SGD","WXIBF","LU0516422366.SGD","LU1720050803.USD","LU0516422952.EUR","IE00B0JY6N72.USD","02269","LU1242518857.USD","LU0043850808.USD","LU1794554557.SGD","BK1576","LU0039217434.USD","LU0856984785.SGD","LU0140636845.USD","LU0823426308.USD","LU0417516902.SGD","LU0819121731.USD","LU0823426480.USD","LU0359202008.SGD"],"gpt_icon":0},{"id":"2558509299","title":"药明生物8月8日成交额为770.00美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2558509299","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558509299?lang=zh_cn&edition=full","pubTime":"2025-08-09 16:34","pubTimestamp":1754728475,"startTime":"0","endTime":"0","summary":"美东时间2025年8月8日,药明生物成交额为770.00美元,当日成交量为200.00股。药明生物于2025年8月8日涨0.0%,报3.85美元,该股过去5个交易日跌4.94%,年初至今涨77.42%,过去60日涨28.33%。它成立于 2010 年,隶属于药明康德,并于 2017 年在香港联交所上市。无锡药明康德报告称,2020年收入为56亿元人民币,三年复合年增长率为51%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250809163441a6dc4f54&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250809163441a6dc4f54&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4121","WXIBF"],"gpt_icon":0},{"id":"2557308822","title":"中华交易服务中国280指数上涨0.58%,前十大权重包含信达生物等","url":"https://stock-news.laohu8.com/highlight/detail?id=2557308822","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557308822?lang=zh_cn&edition=full","pubTime":"2025-08-06 21:37","pubTimestamp":1754487426,"startTime":"0","endTime":"0","summary":"数据统计显示,中华交易服务中国280指数近一个月上涨6.43%,近三个月上涨12.99%,年至今上涨11.95%。从中华交易服务中国280指数持仓的市场板块来看,上海证券交易所占比44.77%、香港证券交易所占比28.45%、深圳证券交易所占比26.78%。从中华交易服务中国280指数持仓样本的行业来看,金融占比18.07%、信息技术占比17.54%、工业占比16.36%、医药卫生占比10.25%、原材料占比10.05%、可选消费占比9.31%、通信服务占比8.04%、主要消费占比3.82%、公用事业占比3.56%、能源占比1.81%、房地产占比1.20%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080621444097378dc3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080621444097378dc3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01801","02269","02611","LU2488822045.USD","BK1161","LU2328871848.SGD","601211","09868","WXIBF","09992","ZIJMY","601628","02899","601899","ZIJMF","688981","LU1969619763.USD","02628","BK1589","00981","BK1583"],"gpt_icon":0},{"id":"2557361873","title":"药明生物8月4日成交额为5339.00美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557361873","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557361873?lang=zh_cn&edition=full","pubTime":"2025-08-05 16:12","pubTimestamp":1754381537,"startTime":"0","endTime":"0","summary":"美东时间2025年8月4日,药明生物成交额为5339.00美元,成交额较昨日增加31.99%,当日成交量为1388.00股。药明生物于2025年8月4日跌4.82%,报3.85美元,该股过去5个交易日跌4.94%,年初至今涨77.42%,过去60日涨28.33%。它成立于 2010 年,隶属于药明康德,并于 2017 年在香港联交所上市。无锡药明康德报告称,2020年收入为56亿元人民币,三年复合年增长率为51%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250805164235a6d41d90&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250805164235a6d41d90&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4121","WXIBF"],"gpt_icon":0},{"id":"2557330948","title":"百济神州要切入“CXO”,赛道未来是生态局?","url":"https://stock-news.laohu8.com/highlight/detail?id=2557330948","media":"盖德化工网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557330948?lang=zh_cn&edition=full","pubTime":"2025-08-05 08:00","pubTimestamp":1754352034,"startTime":"0","endTime":"0","summary":"百济神州“组局”,想切入CXO?据分析,百济神州在美国已拥有完整的临床和商业化团队,邀请国内新药组局“NewCo出海”,很有可能想切入“CXO”领域:一是百济神州全球组建有超3700人的临床团队,需要大量的资金用以维持这支庞大团队的高速运转。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250805081046a4754452&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250805081046a4754452&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0588546209.SGD","01875","LU2328871848.SGD","688235","WXIBF","BK1500","06160","BK1583","BK1588","LU1969619763.USD","02142","BK1161","ONC","02269","LU0307460666.USD"],"gpt_icon":0},{"id":"2556238072","title":"美国OTC市场药明生物盘中异动 早盘股价大跌6.06%报3.80美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2556238072","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2556238072?lang=zh_cn&edition=full","pubTime":"2025-08-04 22:52","pubTimestamp":1754319121,"startTime":"0","endTime":"0","summary":"北京时间2025年08月04日22时52分,美国OTC市场药明生物股票出现波动,股价大幅下挫6.06%。截至发稿,该股报3.80美元/股,成交量100股,换手率0.00%,振幅0.00%。美国OTC市场药明生物股票所在的生物技术行业中,整体涨幅为0.70%。美国OTC市场药明生物公司简介:无锡药明康德集团是一家生物药物的合同开发和制造组织,简称“CDMO”。无锡药明康德报告称,2020年收入为56亿元人民币,三年复合年增长率为51%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250804225201a6d2a0fd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250804225201a6d2a0fd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4121","WXIBF"],"gpt_icon":0},{"id":"2556180183","title":"中证香港内地股等权重指数报2226.67点,前十大权重包含快手-W等","url":"https://stock-news.laohu8.com/highlight/detail?id=2556180183","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2556180183?lang=zh_cn&edition=full","pubTime":"2025-08-04 15:59","pubTimestamp":1754294379,"startTime":"0","endTime":"0","summary":"金融界8月4日消息,上证指数低开高走,中证香港内地股等权重指数 报2226.67点。数据统计显示,中证香港内地股等权重指数近一个月上涨3.50%,近三个月上涨10.41%,年至今上涨21.10%。从中证香港内地股等权重指数持仓的市场板块来看,香港证券交易所占比100.00%。特殊情况下将对中证香港策略指数系列进行临时调整。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080416043097324b68&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080416043097324b68&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0051755006.USD","LU0456827905.SGD","LU1188198961.HKD","LU1719994722.HKD","LU1720050803.USD","LU0348767384.USD","LU0593848301.USD","01378","02628","WXIBF","BK1590","LU0463099449.HKD","81024","86618","KSTmain","LU0588546209.SGD","LU2097828631.EUR","BK1615","688981","02269","LU2097828557.USD","01024","BK1095","LU1794554557.SGD","LU2097828714.EUR","LU0348766576.USD","00981","03692","LU0140636845.USD","LU0244354667.USD","LU0307460666.USD","LU2097828805.USD","LU0326950275.SGD","BK1608","LU1251922891.USD","601628","LU1303224171.USD","LU1770034418.SGD","BK1591","ZIJMF","ZIJMY","06618","09633","BK1575","BK1610","LU2097828474.EUR"],"gpt_icon":1},{"id":"2556386180","title":"中金医药8月组合:看好创新药及产业链 关注政策端积极变化","url":"https://stock-news.laohu8.com/highlight/detail?id=2556386180","media":"中金公司","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2556386180?lang=zh_cn&edition=full","pubTime":"2025-08-04 00:00","pubTimestamp":1754236800,"startTime":"0","endTime":"0","summary":"评论看好创新药长期产业发展趋势。关注创新产业链。受益于年初以来以港股18A为代表的创新药行业繁荣,目前一二级市场投融资一改过去3-4 年的颓势,二季度开始出现较为明显的反转。此外以药明康德为代表的CDMO近期亮眼的中报业绩,体现创新药供应链体系在全球经济不确定性下的经营韧性。期待内需相关政策的积极影响。估值与建议A股:百济神州、恒瑞医药、科伦药业、泰格医药、药明康德、新产业、华大智造、惠泰医疗、迪安诊断。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250804193156a4745b04&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250804193156a4745b04&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01177","LU1115378108.SGD","688617","ONC","ZLAB","SHTDY","09926","SBHMY","01099","688235","03347","09688","02219","06990","01093","06160","BK1515","BK1574","WXIBF","02005","BK1500","09939","LU0640798160.USD","06978","603259","03759","BK1161","00512","688114","BK1197","02269"],"gpt_icon":0},{"id":"2556822836","title":"创新药“狂飙”与CXO“转型”,BD潮涌下的产业变局与新机","url":"https://stock-news.laohu8.com/highlight/detail?id=2556822836","media":"医药经济报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2556822836?lang=zh_cn&edition=full","pubTime":"2025-08-03 14:00","pubTimestamp":1754200801,"startTime":"0","endTime":"0","summary":"至6月底,恒生港股通创新药指数宣布修订编制方案,将CXO企业剔除,转而聚焦创新药核心公司。曾经同涨同跌的创新药与CXO行业,如今呈现出明显的解绑趋势。如此看来,创新药市场的火热态势似乎与CXO行业毫无关联。创新药与CXO行业脱钩曾几何时,创新药与CXO行业在相当长的一段时间内被视为紧密相连、不可分割的整体。创新药与CXO的脱钩,可视为双方产业发展到不同阶段的必然结果。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250803140214a472234a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250803140214a472234a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06821","BK1576","03759","688710","WXIBF","02359","BK1574","BK1161","06127","BK1583","06978","02269","03347","BK1141"],"gpt_icon":0},{"id":"2556947828","title":"药明生物8月1日成交额为4045.00美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2556947828","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2556947828?lang=zh_cn&edition=full","pubTime":"2025-08-02 16:18","pubTimestamp":1754122701,"startTime":"0","endTime":"0","summary":"美东时间2025年8月1日,药明生物成交额为4045.00美元,当日成交量为1000.00股。药明生物于2025年8月1日涨0.0%,报4.05美元,该股过去5个交易日涨1.12%,年初至今涨86.41%,过去60日涨34.83%。它成立于 2010 年,隶属于药明康德,并于 2017 年在香港联交所上市。无锡药明康德报告称,2020年收入为56亿元人民币,三年复合年增长率为51%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250802161824a4710ae5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250802161824a4710ae5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["WXIBF","BK4121"],"gpt_icon":0},{"id":"2556586095","title":"中证沪港深500医药卫生指数下跌1.74%,前十大权重包含恒瑞医药等","url":"https://stock-news.laohu8.com/highlight/detail?id=2556586095","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2556586095?lang=zh_cn&edition=full","pubTime":"2025-08-01 15:48","pubTimestamp":1754034492,"startTime":"0","endTime":"0","summary":"数据统计显示,中证沪港深500医药卫生指数近一个月上涨17.84%,近三个月上涨24.27%,年至今上涨34.48%。从中证沪港深500医药卫生指数持仓的市场板块来看,香港证券交易所占比37.87%、上海证券交易所占比33.61%、深圳证券交易所占比28.52%。从中证沪港深500医药卫生指数持仓样本的行业来看,化学药占比36.20%、制药与生物科技服务占比18.33%、生物药品占比18.14%、医疗器械占比11.07%、中药占比8.56%、医疗商业与服务占比7.70%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080115594994c860b0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080115594994c860b0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["603259","01093","WXIBF","688271","01801","02269","688235","01177","600276","BK1191","01276","ONC","09926","SBHMY","06160","02359"],"gpt_icon":1},{"id":"2555012771","title":"图解丨南下资金净买入港股117亿港元,大幅加仓理想汽车","url":"https://stock-news.laohu8.com/highlight/detail?id=2555012771","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555012771?lang=zh_cn&edition=full","pubTime":"2025-07-30 17:44","pubTimestamp":1753868696,"startTime":"0","endTime":"0","summary":"格隆汇7月30日|南下资金今日净买入港股117.14亿港元。其中: 净买入理想汽车-W 20.93亿、石药集团8.72亿、美团-W 4.47亿、阿里巴巴-W 3.57亿、腾讯控股1.83亿、巨星传奇1.75亿、药明生物1.71亿、小米集团-W 1.48亿; 净卖出中芯国际2.05亿、信达生物1.21亿。 据统计,南下资金已连续5日净买入腾讯,共计22.724亿港元;连续4日净买入阿里巴巴,共计16.3018亿港元。(格隆汇)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025073017541197278190&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025073017541197278190&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1610","LU1794554557.SGD","LI","09988","BK1607","07226","BK1119","BK1526","LU1720050803.USD","02015","06683","BK1614","HSCEI","HSTECH","02269","03690","WXIBF","BK1588","BK1575","BK1539","BK1163","00981","BK1587","01810"],"gpt_icon":0},{"id":"2555609921","title":"药明生物再涨超3%宣布新加坡CRDMO中心模块化生物制剂生产厂启动建设","url":"https://stock-news.laohu8.com/highlight/detail?id=2555609921","media":"动脉网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555609921?lang=zh_cn&edition=full","pubTime":"2025-07-30 11:09","pubTimestamp":1753844940,"startTime":"0","endTime":"0","summary":"药明生物宣布在新加坡启动模块化生物制剂生产厂建设,配备先进生产线和实验室,支持多种剂型生产,预计2027年投入运营。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025073011211794c2eb29&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025073011211794c2eb29&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["WXIBF","BK4121"],"gpt_icon":0},{"id":"2555032398","title":"药明生物7月28日成交额为3236.00美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2555032398","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555032398?lang=zh_cn&edition=full","pubTime":"2025-07-29 16:41","pubTimestamp":1753778504,"startTime":"0","endTime":"0","summary":"美东时间2025年7月28日,药明生物成交额为3236.00美元,成交额较昨日减少71.11%,当日成交量为800.00股。药明生物于2025年7月28日涨1.12%,报4.05美元,该股过去5个交易日涨11.43%,年初至今涨86.41%,过去60日涨34.83%。它成立于 2010 年,隶属于药明康德,并于 2017 年在香港联交所上市。无锡药明康德报告称,2020年收入为56亿元人民币,三年复合年增长率为51%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250729172417a469629c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250729172417a469629c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["WXIBF","BK4121"],"gpt_icon":0},{"id":"2554744063","title":"【医药】集采“反内卷”,关注受益标的——医药生物行业周报","url":"https://stock-news.laohu8.com/highlight/detail?id=2554744063","media":"渤海证券研究","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2554744063?lang=zh_cn&edition=full","pubTime":"2025-07-28 09:13","pubTimestamp":1753665229,"startTime":"0","endTime":"0","summary":"集采规则持续优化,建议关注受益于集采规则优化的制药和医疗器械板块。综上,我们维持行业“看好”评级。订阅者应当充分了解各类投资风险,根据自身情况自主做出投资决策并自行承担投资风险。如因侵权行为给渤海证券造成任何直接或间接损失,渤海证券保留追究一切法律责任的权利。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072809265194be4461&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072809265194be4461&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02269","BK4121","WXIBF","02268"],"gpt_icon":0},{"id":"2553276812","title":"药明生物涨4% 料中期净利同比增长约56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2553276812","media":"金吾资讯","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2553276812?lang=zh_cn&edition=full","pubTime":"2025-07-24 13:36","pubTimestamp":1753335407,"startTime":"0","endTime":"0","summary":"消息面上,药明生物公布,根据对集团截至2025年6月30日止六个月的未经审核综合管理账目的初步评估,集团预期与去年同期比较,截至2025年6月30日止六个月所录得的公司收益将增长约16%;毛利率将同比提升约3.6%;公司截至2025年6月30日止六个月的利润及归属于公司权益股东的利润相比于去年同期将分别增长约54%和约56%;以及经调整股份为基础的薪酬开支、外汇损益及股权投资损益后,公司非国际财务报告准则经调整纯利将增长约11%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250724133738971b5091&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250724133738971b5091&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0320764599.SGD","02269","LU0052750758.USD","LU1880383366.USD","LU0456827905.SGD","LU0307460666.USD","LU0588546209.SGD","LU0348825331.USD","SG9999002562.SGD","LU0417516738.SGD","LU0359201612.USD","WXIBF","LU0979878070.USD","SG9999002463.SGD","LU0326950275.SGD","LU0516422366.SGD","LU0856984785.SGD","BK1576","LU0043850808.USD","LU1688375341.USD","LU0140636845.USD","LU0823426308.USD","BK1610","LU0516423091.SGD","LU1242518931.SGD","BK1589","BK1521","IE00B0JY6N72.USD","LU0327786744.USD","LU0572944931.SGD","LU0456846285.SGD","LU1242518857.USD","LU0417516902.SGD","LU0708995583.HKD","LU0516422952.EUR","LU2039709279.SGD","LU0359202008.SGD","LU0516422440.USD","LU0039217434.USD","LU0819121731.USD","LU0181495838.USD","LU0348735423.USD","LU1794554557.SGD","BK1141","LU0823426480.USD","LU0051755006.USD","LU0516423174.USD","LU1720050803.USD"],"gpt_icon":0},{"id":"2553801226","title":"药明生物拟8月19日举行董事会会议批准中期业绩","url":"https://stock-news.laohu8.com/highlight/detail?id=2553801226","media":"格隆汇","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2553801226?lang=zh_cn&edition=full","pubTime":"2025-07-24 07:19","pubTimestamp":1753312797,"startTime":"0","endTime":"0","summary":"格隆汇7月24日丨药明生物(02269.HK)宣布,公司谨订于2025年8月19日(星期二)在香港举行董事会会议,藉以(其中包括)考虑及批准集团截至2025年6月30日止六个月的中期业绩及其刊发。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250724072010971ab4bd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250724072010971ab4bd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0348825331.USD","LU0327786744.USD","LU0856984785.SGD","LU1720050803.USD","LU0456846285.SGD","WXIBF","LU0588546209.SGD","LU0819121731.USD","BK1576","LU0979878070.USD","LU0572944931.SGD","LU0823426308.USD","LU0140636845.USD","LU0516422440.USD","LU0307460666.USD","LU0708995583.HKD","LU0320764599.SGD","LU0417516738.SGD","SG9999002463.SGD","BK1589","LU1880383366.USD","LU1688375341.USD","BK1521","02269","LU0516423091.SGD","LU0359202008.SGD","LU0039217434.USD","LU2039709279.SGD","LU0043850808.USD","LU1242518931.SGD","LU0348735423.USD","LU0326950275.SGD","LU0417516902.SGD","LU0516422366.SGD","LU0359201612.USD","LU0456827905.SGD","LU0516422952.EUR","LU0052750758.USD","LU0516423174.USD","LU0051755006.USD","IE00B0JY6N72.USD","LU0181495838.USD","BK1610","SG9999002562.SGD","LU1794554557.SGD","BK1141","LU1242518857.USD","LU0823426480.USD"],"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0.1576},{"period":"6month","weight":-0.0314},{"period":"1year","weight":0.3021},{"period":"ytd","weight":0.6619}],"exchange":"PINK LIMITED","name":"Wuxi Biologics (Cayman) Inc","nameEN":"Wuxi Biologics (Cayman) Inc"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.9","shortVersion":"4.35.9","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Wuxi Biologics (Cayman) Inc(WXIBF)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Wuxi Biologics (Cayman) Inc(WXIBF)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Wuxi Biologics (Cayman) Inc,WXIBF,Wuxi Biologics (Cayman) Inc股票,Wuxi Biologics (Cayman) Inc股票老虎,Wuxi Biologics (Cayman) Inc股票老虎国际,Wuxi Biologics (Cayman) Inc行情,Wuxi Biologics (Cayman) Inc股票行情,Wuxi Biologics (Cayman) Inc股价,Wuxi Biologics (Cayman) Inc股市,Wuxi Biologics (Cayman) Inc股票价格,Wuxi Biologics (Cayman) Inc股票交易,Wuxi Biologics (Cayman) Inc股票购买,Wuxi Biologics (Cayman) Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Wuxi Biologics (Cayman) Inc(WXIBF)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Wuxi Biologics (Cayman) Inc(WXIBF)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}